LINC00942 and glioblastoma: We further confirmed that TPI1 and PKM2, but not PKM1, interacted significantly with Linc00942 using ChIRP‐WB (Figure 2C; Figure S6F, Supporting Information) and RNA immunoprecipitation (RIP) assays (Figure 2D; Figure S6G,H, Supporting Information) in both TMZ‐resistant and Linc00942‐overexpressing GBM cells.